Inovio Pharmaceuticals Inc (NASDAQ: INO) stock enjoyed a major increase of 10.5% on 2/27/24. The shares closed at $9.02. Moreover, this advance was accompanied by above average trading volume at 141% of normal. Relative to the market the stock has been strong over the last nine months and has risen 13.7% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, INO is expected to continue to be Value Creation neutral.
Inovio Pharmaceuticals has a current Value Trend Rating of C (Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing contradictory signals. Inovio Pharmaceuticals has a slightly negative Appreciation Score of 33 but a good Power Rating of 73, and the Neutral Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment